Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Goodwill & Intangibles (2020 - 2025)

Neuphoria Therapeutics (NEUP) has disclosed Goodwill & Intangibles for 5 consecutive years, with $13.2 million as the latest value for Q4 2025.

  • Quarterly Goodwill & Intangibles fell 2.45% to $13.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.2 million through Dec 2025, down 2.45% year-over-year, with the annual reading at $13.4 million for FY2025, N/A changed from the prior year.
  • Goodwill & Intangibles for Q4 2025 was $13.2 million at Neuphoria Therapeutics, down from $13.3 million in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $16.3 million in Q2 2022, with the low at $13.2 million in Q4 2025.
  • Average Goodwill & Intangibles over 4 years is $14.0 million, with a median of $13.5 million recorded in 2024.
  • The sharpest move saw Goodwill & Intangibles fell 8.41% in 2023, then decreased 2.45% in 2025.
  • Over 4 years, Goodwill & Intangibles stood at $16.3 million in 2022, then decreased by 8.41% to $14.9 million in 2023, then decreased by 9.08% to $13.5 million in 2024, then fell by 2.45% to $13.2 million in 2025.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods came in at $13.2 million, $13.3 million, and $13.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.